Asia Pacific stocks were mixed on Tuesday morning, giving up some earlier gains after optimism over the latest positive COVID-19 vaccine news fizzled.
Moderna Inc (NASDAQ:MRNA) became the latest pharmaceutical company to report a positive development when t said on Monday that its candidate mRNA-1273 had a 94.5% efficacy rate from the results of a large, late-stage phase III COVE study. The news follows Pfizer Inc's (NYSE:PFE) announcement during the previous week that its candidate, BNT162b, that is being co-developed with Germany’s BioNTech (F:22UAy), prevented more than 90% of symptomatic infections.
Moderna’s news saw the company’s shares climbed up to 15% and helped U.S. shares see record highs over hopes of a quick economic recovery.
Japan’s Nikkei 225 edged up 0.20% by 11:27 PM ET (3:27 AM GMT).
South Korea’s KOSPI edged up 0.14%.
In Australia, the ASX 200 was up 0.33% while Hong Kong’s Hang Seng Index inched down 0.01%.
China’s Shanghai Composite edged down 0.19% and the Shenzhen Component slid 1.22%.
For more information please refer to the original article: https://www.investing.com/news...
免責事項：本記事で述べられている見解は著者の見解のみであり、Followmeの公式見解を反映するものではありません。Followmeは、提供された情報の正確性、完全性、信頼性について一切責任を負いません。また、書面で明示的に記載されている場合を除き、本記事の内容に基づいて行われたいかなる行動についても責任を負いません。
古いコメントはありません。ソファをつかむ最初のものになりましょう。